Company CVAbout Vivanza Biosciences Ltd 
Vivanza Biosciences Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Vivanza Biosciences Limited, formerly known as Ivee Injectaa Limited was established in March, 1982 as a Private Limited Company and was later on, converted into a Public Limited Company in May, 1992. Due to recessionary trends which lead to difficult business conditions in year 1999-2000, the parenteral industry suffered a setback and due to this, the name of the Company was changed from Ivee Injectaa Limited to Vivanza Biosciences Limited in 2015.
Company Coordinates
Company Details
403 Sarthik 2 Opp Rajpath Club, S G Highway Ahmedabad Gujarat : 380054
Registrar Details
Purva Shareregistry (India) Pvt Ltd , Gala No 9, Shiv Shakti, Industrial Estate,Sitaram Mill Comp., J R Boricha Marg, Lower Parel [E], Mumbai
Capital StructureCapital Structure
Present Equity Capital
INR 4.00 Cr
Number of Shares
4 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
30-Mar-2017
4
4.00
1450000
10
Conversion of Warrants
17-Jun-2016
25.5
2.55
2362000
10
Allotment of Equity To Others
16-Jun-2016
25.5
2.55
2362000
10
Allotment of Equity To Others
27-May-2015
1.88
0.19
-3572000
10
Capital Reduction
26-May-2015
1.88
0.19
-3572000
10
Capital Reduction
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Non Institution
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Parth Hemant Parikh (19.77%)
Highest Public shareholder
Ravinder Singh (1.7%)
Individual Investors Holdings
73.49%
Board of Directors
Management
Designation
Remuneration
Hemant Parikh
Director
0
Sunil Shah
Independent Director
0
Avinash G. Bhojwani
Company Sec. & Compli. Officer
4.57 lacs
Apeksha Vyas
Independent Director
0
Jayendra Mehta
Managing Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
No Data Available for Finished Goods Segmentation
No Data Available
Stock DNARevenue and Profits:
Net Sales:
9 Cr
(Quarterly Results - Jun 2026)
Net Profit:
0 Cr
Pharmaceuticals & Biotechnology
INR 7 Cr (Micro Cap)
15.00
31
0.00%
2.32
9.17%
1.65
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
